RxDoctor Payments Data

Vanessa Ramsey, APRN

Family · Kaufman, TXNPI 1003678269

Payments from drug & device makers

$3,348in general payments, 2019–2025

Across 174 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$483
  • AbbVie$463
  • Novo Nordisk$361
  • Lilly USA, LLC$243
  • Pfizer$226
  • Sanofi-aventis U.S. LLC$179
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$3,348100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,348 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$41,534
Medicare patients
235
Services billed
1,491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$15,774
JardianceEmpagliflozin14$12,197
OzempicSemaglutide11$10,346
XareltoRivaroxaban13$9,373
Gabapentin84$1,596
Albuterol Sulfate HfaAlbuterol Sulfate66$1,547
Levothyroxine Sodium98$781
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav68$736
Methylprednisolone105$721
Fluticasone Propionate49$677
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst47$597
Celecoxib29$553
Omeprazole32$538
ValacyclovirValacyclovir Hcl15$439
Duloxetine Hcl29$417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$226$15,77413 claims
Boehringer IngelheimJardiance$14$12,19714 claims
Novo NordiskOzempic$361$10,34611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 15,456 family providers in Texas.

Other family in Kaufman

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →